Soro-Paavonen Aino, Westerbacka Jukka, Ehnholm Christian, Taskinen Marja-Riitta
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Finland.
Ann Med. 2006;38(3):229-38. doi: 10.1080/07853890500526352.
Inhibition of cytokine-induced expression of adhesion molecules is one of the atheroprotective mechanisms of high-density lipoprotein (HDL).
We investigated whether increased endothelial activation and low-grade inflammation are present in Finnish subjects with familial low HDL, and which factors contribute to the inflammatory parameters.
High-sensitivity C-reactive protein (hsCRP), soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), and sE-selectin were measured in 91 subjects with low HDL-cholesterol from 41 low-HDL families and in 112 normolipidemic controls with comparable age- and gender distribution. Presence of the features of the metabolic syndrome (MetS) was recorded.
sVCAM-1, sICAM-1, sE-selectin, and hsCRP were significantly higher in low-HDL subjects than in the controls (sVCAM-1: 560+/-147 ng/mL versus 496+/-95 ng/mL, P = 0.001; sICAM-1: 247+/-60 ng/mL versus 215+/-47 ng/mL, P<0.001; sE-selectin: 52+/-20 ng/mL versus 44+/-16 ng/mL, P = 0.022; and hsCRP: 1.73+/-2.05 mg/L versus 0.85+/-1.10 mg/L, P<0.001). Low-HDL subjects had increased body mass index (BMI) and waist, and elevated insulin and triglyceride levels. Adhesion molecules and hsCRP increased according to the number of the features of the MetS.
The presence of the MetS in subjects with familial low HDL-cholesterol aggravates the low-grade inflammation and endothelial activation, and ultimately may add to the higher susceptibility for atherosclerotic disease in these individuals.
抑制细胞因子诱导的黏附分子表达是高密度脂蛋白(HDL)的动脉粥样硬化保护机制之一。
我们研究了芬兰家族性低HDL受试者是否存在内皮激活增加和低度炎症,以及哪些因素影响炎症参数。
对来自41个低HDL家族的91名低HDL胆固醇受试者和112名年龄和性别分布相当的血脂正常对照者测量高敏C反应蛋白(hsCRP)、可溶性细胞间黏附分子-1(sICAM-1)、血管细胞黏附分子-1(sVCAM-1)和sE-选择素。记录代谢综合征(MetS)特征的存在情况。
低HDL受试者的sVCAM-1、sICAM-1、sE-选择素和hsCRP显著高于对照组(sVCAM-1:560±147 ng/mL对496±95 ng/mL,P = 0.001;sICAM-1:247±60 ng/mL对215±47 ng/mL,P<0.001;sE-选择素:52±20 ng/mL对44±16 ng/mL,P = 0.022;hsCRP:1.73±2.05 mg/L对0.85±1.10 mg/L,P<0.001)。低HDL受试者的体重指数(BMI)和腰围增加,胰岛素和甘油三酯水平升高。黏附分子和hsCRP随MetS特征数量的增加而升高。
家族性低HDL胆固醇受试者中MetS的存在会加重低度炎症和内皮激活,最终可能增加这些个体患动脉粥样硬化疾病的易感性。